Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus

Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice

(2018) Janelle Rowell et al.   VACCINE

Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size

(2017) Henrik Salje et al.   SCIENCE

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

(2016) Beth D. Kirkpatrick et al.   Science Translational Medicine

The Lymphocytic Choriomeningitis Virus Matrix Protein PPXY Late Domain Drives the Production of Defective Interfering Particles

(2016) Christopher M. Ziegler et al.   PLoS Pathogens

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

(2015) Beth D. Kirkpatrick et al.   JOURNAL OF INFECTIOUS DISEASES

Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

(2015) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

Dengue viruses cluster antigenically but not as discrete serotypes

(2015) L. C. Katzelnick et al.   SCIENCE

Dose-Response Analysis Using R

(2015) Christian Ritz et al.   PLoS One

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

(2014) Jorge E Osorio et al.   LANCET INFECTIOUS DISEASES

Time-varying, serotype-specific force of infection of dengue virus

(2014) Robert C. Reiner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Variability in Dengue Titer Estimates from Plaque Reduction Neutralization Tests Poses a Challenge to Epidemiological Studies and Vaccine Development

(2014) Henrik Salje et al.   PLoS Neglected Tropical Diseases

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development

(2013) Tatyana M. Timiryasova et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics

(2013) Scott A. Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection

(2013) S. Sukupolvi-Petty et al.   JOURNAL OF VIROLOGY

Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year

(2013) Magelda Montoya et al.   PLoS Neglected Tropical Diseases

Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine

(2011) Anna P. Durbin et al.   VACCINE

EBImage--an R package for image processing with applications to cellular phenotypes

(2010) G. Pau et al.   BIOINFORMATICS

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

(2009) Stephen J. Thomas et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE